Critical Medical Device Series: Part IV IP Considerations for Diagnostics and Biomarkers Section 101

MedTech companies are continuously innovating cutting-edge technologies to improve healthcare. Whether your company is developing stand-alone diagnostic solutions or partnering with others to create companion diagnostics, patents may be a critical component of your business strategy for protecting innovations and generating revenue.

Arnold & Porter partner David Marsh and senior associate Alice Ho will discuss effective strategies for prosecuting diagnostics and biomarkers patent applications. This program will provide you with insights into navigating current subject matter eligibility case law and potential legislative reforms, helping you future-proof your patent portfolio.

Webinar Series Alert